Welcome to our dedicated page for VRNO news (Ticker: VRNO), a resource for investors and traders seeking the latest updates and insights on VRNO stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VRNO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VRNO's position in the market.
Verano (VRNO) announced on December 2, 2025 that the Texas Department of Public Safety awarded the company a conditional Dispensing Organization License under Phase 1 of the state’s Compassionate Use Program expansion. Subject to final state approval after further due diligence, the license permits Verano to cultivate, process and dispense medical cannabis across Texas.
Verano said it currently operates in 13 states with 158 Zen Leaf and MÜV dispensaries, 15 cultivation and processing facilities, and over 1.1 million sq ft of cultivation capacity, and plans to offer Texas-grown medical products if final approvals are granted.
FAQ
What is the current stock price of VRNO (VRNO)?
